Giacomo D'andrea
Chieti, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Esketamine-based treatment, depression-specific metacognitive training, and their combination in treatment-resistant depression: 6-month trajectories of depressive symptoms and rumination in a multicenter observational study.
Journal: European archives of psychiatry and clinical neuroscience
Published: June 12, 2026
Real-world effectiveness and tolerability of desvenlafaxine in major depressive disorder: A multicentre prospective Italian national-cohort study.
Journal: Psychiatry research
Published: May 01, 2026
Prefrontal transcranial direct current stimulation in alcohol use disorder: a pilot randomized sham-controlled trial with exploratory effects on reward craving and depressive symptoms.
Journal: Addictive behaviors
Published: March 24, 2026
Preliminary Evidence on the Efficacy and Tolerability of Quetiapine in Dual Disorders: A Prospective, Multicentric, Real-World Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 19, 2026
Dimensional effect profiles in treatment-resistant depression: A naturalistic, prospective head-to-head comparison of arTMS, esketamine nasal spray, and oral brexpiprazole.
Journal: Journal of affective disorders
Published: January 08, 2026
Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care.
Journal: Translational psychiatry
Published: August 19, 2025
Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group.
Journal: Psychiatry research
Published: June 11, 2025
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).
Journal: Journal of personalized medicine
Published: March 06, 2025
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: August 08, 2024
Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.
Journal: Current medical research and opinion
Published: June 11, 2024
An open-label pilot trial of a five-day, accelerated rTMS protocol in bipolar II depression.
Journal: Journal of affective disorders
Published: May 28, 2024
Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project).
Journal: Frontiers in psychiatry
Published: May 21, 2024
Last Updated: 09/26/2026